In the original article, there was a mistake in Figure 1 as published. In Figure 1F, the number “42” should be “38”. The corrected Figure 1 appears below.
Figure 1
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
breast cancer, STAT5A, ABCB1, pimozide, doxorubicin resistance
Citation
Li Z, Chen C, Chen L, Hu D, Yang X, Zhuo W, Chen Y, Yang J, Zhou Y, Mao M, Zhang X, Xu L, Ju S, Shen J, Wang Q, Dong M, Xie S, Wei Q, Jia Y, Zhou J and Wang L (2022) Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1. Front. Oncol. 12:880458. doi: 10.3389/fonc.2022.880458
Received
21 February 2022
Accepted
23 February 2022
Published
09 March 2022
Volume
12 - 2022
Edited and reviewed by
Dayanidhi Raman, University of Toledo, United States
Updates
Copyright
© 2022 Li, Chen, Chen, Hu, Yang, Zhuo, Chen, Yang, Zhou, Mao, Zhang, Xu, Ju, Shen, Wang, Dong, Xie, Wei, Jia, Zhou and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Linbo Wang, linbowang@zju.edu.cn; Jichun Zhou, jichun-zhou@zju.edu.cn
†These authors have contributed equally to this work and share first authorship
This article was submitted to Breast Cancer, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.